Clinical Trials
4 trialsNCT07622888 2026-06-03
GIDNUT
Arma Ltd.
Not yet recruiting
NCT06274788 2025-09-05
Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment
Fresenius Kabi
Recruiting
NCT04807478 2022-08-04
Safety of Omegaven in Pediatric Patients With Parenteral Nutrition-Associated Cholestasis (PNAC)
Fresenius Kabi
Withdrawn
NCT02968979 2019-09-24
CacheMire
Chugai Pharma France
Completed